Drug Database
AL

alpha-1 antitrypsin (Alfalastin / rhAAT, GTC)

✓ Approved

rEVO Biologics · SERPINA1 · 重组蛋白

什么是 alpha-1 antitrypsin?

alpha-1 antitrypsin 是一种重组蛋白,由rEVO Biologics研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

商品名Alfalastin, rhAAT, GTC
公司rEVO Biologics
药物类别重组蛋白
分子靶点SERPINA1
给药途径Unknown
状态Approved

作用机制

分子靶点

alpha-1 antitrypsin 作用于 1 个分子靶点:

SERPINA1serpin family A member 1 (PRO2275, nNIF)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

alpha-1 antitrypsin 针对 3 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Congenital, familial and genetic disordersCongenital emphysema✓ Approved
Skin and subcutaneous tissue disordersDermatitis allergicPreclinical
Skin and subcutaneous tissue disordersDermatitis atopicPreclinical

相关研究文献

PubMedNature communications2026-11-18

Posterior alpha/beta oscillations reflect oculomotor dynamics underlying subsequent memory effects.

Wu Xiongbo X, Popov Tzvetan T, Beilner Tara T, Fearns Nicholas N et al.

Neural activity and eye movements are well-established predictors of human memory performance. Successful memory formation is associated with reduced alpha/beta power and increased eye movements. However, their coupling and combined contribution to memory formation remain largely unknown. Across four experiments combining eye tracking with scalp or intracranial electroencephalography during free or constrained viewing, we identify the degree of visual exploration, rather than subsequent memory performance, as consistent modulator of posterior alpha/beta power. Going beyond correlations, manipulating eye movements dissociated alpha/beta power reductions from memory. Together with the finding that saccade parameters predicted alpha/beta dynamics, our results directly link posterior alpha/beta activity to the oculomotor system. Moreover, the accumulation of saccades over time accounted for reduced alpha/beta power, resembling the canonical post-stimulus alpha/beta pattern. Our work demonstrates that posterior alpha/beta activity strongly reflects eye movements, supporting alternative perspectives on alpha/beta subsequent memory effects and the general function of posterior alpha/beta activity.

PMID 43045723
阅读全文 →
PubMedClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026-11-18

The CD1d-iNKT Axis Modulates Allergic Responses to Alpha-Gal.

Wang Yinghui Y, Rival Claudia M CM, Zhang Yugen Y, Vasan Soorya S et al.

Amblyomma americanum (Aa or lone star tick) bites can induce alpha-gal syndrome (AGS)-allergic responses to mammal products linked to galactose-alpha-1,3-galactose (alpha-gal or α-Gal)-specific (s)IgE. Peripheral blood mononuclear cells in AGS show increased CD4+T cell-associated gene expression and expansion of CD1d-restricted invariant natural killer T (iNKT) cells. Whether tick exposure activates these T cell subpopulations to promote α-Gal-sIgE and dietary α-Gal-specific hypersensitivity responses remains unclear. We injected α-Gal-deficient (AGKO) mice on a C57BL/6J background with: (1) protein-rich Aa tick whole body extracts with or without anti-CD1d monoclonal antibody 19G11; (2) iNKT lipid activator α-galactosylceramide plus α-Gal glycoprotein (cetuximab) or (3) lipid-enriched Aa tick whole body extracts. We profiled circulating CD4+T and/or iNKT cell subsets and measured serum cytokines and α-Gal-specific and total IgE and IgG1. We infested AGKO mice with adult Aa ticks to determine if AGS-associated tick bites altered CD4+ T and iNKT populations. We measured serum mast cell mediators after oral challenge with α-Gal-containing beef thyroglobulin to assess dietary α-Gal-induced mast cell activation. Tick extract injections induced α-Gal sIgG1, expanded circulating Th2 cells, promoted systemic type 2 (T2)-skewed cytokine responses, and primed for dietary alpha-gal-induced mast cell activation in AGKO mice. Activating iNKT cells with alpha-galactosylceramide concurrent with cutaneous α-Gal-glycoprotein injections, or with lipid-enriched tick extracts alone, induced α-Gal-sIgE. Disrupting CD1d-iNKT cell interactions blunted T2 cytokine-producing iNKT cell expansion induced by tick lipids; α-Gal-sIgE production; and α-Gal-induced mast cell activation. Importantly, infesting with adult Aa ticks increased circulating activated iNKT and Th2 cell frequencies and systemic IL-4, α-Gal sIgG1, and sIgE levels, priming mast cells for degranulation after dietary α-Gal challenge. CD1d-iNKT cell interactions may enhance early T2 cytokine production induced by tick bite, supporting α-Gal sIgE production and amplifying α-gal-induced mast cell degranulation primed by tick-induced, systemic T2-skewing.

PMID 43049226
阅读全文 →
PubMedOrthopaedic journal of sports medicine2026-11-18

Arthroscopic Surgery Versus Sham Surgery for Femoroacetabular Impingement Syndrome and/or Labral Tears: A Double-Blind Randomized Controlled Pilot Trial (HIPARTI).

Warholm Kristian Marstrand KM, Hibbert Elsie E, Ageberg Eva E, Pålsson Anders A et al.

Femoroacetabular impingement syndrome is a common cause of hip pain in young adults. Hip arthroscopy has demonstrated substantial improvements in observational studies and several randomized trials comparing surgery with physical therapist-led treatment; however, randomized placebo-controlled trials remain scarce. The primary aim was to compare arthroscopic surgery with sham surgery on hip-related quality of life at 1 year, measured with the 33-item International Hip Outcome Tool (iHOT-33). Secondary aims were to evaluate effects on patient-reported outcomes, hip strength, range of motion, functional performance, and radiographic measures. It was hypothesized that arthroscopic surgery would yield superior iHOT-33 scores. Randomized controlled trial; Level of evidence, 2. Patients were randomized to arthroscopic surgery or sham surgery followed by a 3-month, physical therapist-led, postsurgical rehabilitation program. The primary outcome was the between-group difference in iHOT-33 at 1 year. Secondary outcomes included Hip disability and Osteoarthritis Outcome Score (HOOS) scores, hip range of motion, isometric hip strength, functional performance, and radiographic changes. Follow-up measurements were performed at 6 months, 1 year, and 2 years. A total of 30 patients (31 hips; mean age, 30.0 ± 7.9 years; 63% male) were included. No significant differences in iHOT-33 scores were observed between the surgical and sham surgical groups at 1 year (P = .08), or 2 years (P = .54). Both groups showed improvements exceeding the minimal clinically important difference (MCID), with the surgical group demonstrating the greatest gains at 2 years (mean changes: 17.4 at 6 months; 21.7 at 1 year; 32.1 at 2 years). Both groups improved; HOOS Pain reached MCID earlier in the sham surgery group (6 months) and at 1 year in the surgical group, with more sustained improvement in the surgical group at 2 years. Strength and functional performance improved in both groups, but the surgical group showed greater gains in side bridge endurance and single-leg hop performance at 2 years. Radiographs confirmed normalization of alpha angle in the surgical group, with reductions in alpha angle on anteroposterior and Dunn 45º/20º views at 1-year follow-up. Arthroscopic surgery did not demonstrate superiority over sham surgery for iHOT-33 at any time point. Both groups improved, but the surgical group showed more consistent and clinically meaningful gains in secondary outcomes and achieved substantial radiographic cam correction. Given the limited sample size, the study was underpowered to detect between-group differences. A fully powered multicenter RCT is warranted to confirm these findings. NCT02692807 (ClinicalTrials.gov identifier).

PMID 43048294
阅读全文 →
PubMedJournal of oral and maxillofacial pathology : JOMFP2026-11-18

Estimation and comparison of the salivary and serum nitric oxide levels in patients with oral squamous cell carcinoma: A cross-sectional study.

Arthy Kandasamy K, SriChinthu KenniyanKumar K, Rajmohan Muthusamy M, Prasad Harikrishnan H et al.

Nitric oxide (NO) is a colourless, water-soluble, and free radical gas with a very short life span. NO acts as a double-edged sword that has both tumorigenic and tumoricidal properties. This study was conducted to estimate and compare the salivary and serum NO levels in healthy individuals and histopathologically diagnosed cases of oral squamous cell carcinoma (OSCC). In this study, the salivary and serum NO levels were estimated in 30 healthy controls and 30 patients with OSCC using a Griess reagent and a multimode reader. Statistical analysis was performed using the independent t-test and Pearson's correlation coefficient. The mean and standard deviation (SD) of salivary NO levels in the healthy control group (Group I) were 0.7588 ± 0.0004 μg/μL, while in the OSCC group (Group II), it was 0.7598 ± 0.0005 μg/μL. Similarly, the mean and the SD of serum NO levels in the control group were 0.7591 ± 0.0003 μg/μL, while in the OSCC group, it was 0.7645 ± 0.0019 μg/μL. NO has a multidimensional role in carcinogenesis. The possible molecular mechanism behind the increased level of NO in OSCC could be correlated with the chronic inflammatory environment, which leads to oxidative damage of DNA through activation of various transcription factors, namely Nuclear Factor-kappa B (Nf kB), Hypoxia-Inducible Factor 1-alpha (HIF-1 alpha), and Signal Transducer and Activator of Transcription 3 (STAT3), which result in tumor growth and progression. Our study demonstrates that increased serum and saliva NO levels are seen in OSCC patients. Hence NO can be used as a diagnostic marker.

PMID 43048636
阅读全文 →
PubMedJPGN reports2026-11-18

Novel pathogenic variant in haploinsufficiency of A20 with severe gastrointestinal effects and fulminant hepatic failure: A pediatric case series.

Blake Amanda A, Cheng Katherine K, Wen Kwun Wah KW, Byers Joshua J et al.

Haploinsufficiency of A20 (HA20) is a rare autoinflammatory disorder caused by heterozygous loss-of-function variants in tumor necrosis factor alpha-induced protein 3 (TNFAIP3), encoding a negative regulator of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) signaling. We report two pediatric patients with a previously unreported novel pathogenic variant (p. Glu409*) in the zinc finger (ZnF) 1 domain, exhibiting markedly divergent phenotypes. Case 1 presented with very-early-onset inflammatory bowel disease (VEO-IBD) and autoimmune thyroiditis, requiring aggressive infliximab dose escalation. Case 2 developed fulminant hepatic failure requiring liver transplantation, followed by post-transplant complications including refractory rejection, recurrent infections, and post-transplant lymphoproliferative disorder. This represents the first known case of HA20 in solid organ transplantation. These cases underscore the importance of early genetic diagnosis in unexplained pediatric inflammatory disease and transplant rejection, as HA20 recognition may alter immunosuppressive strategies and guide therapies including cytokine blockade or Janus kinase (JAK) inhibition.

PMID 43048450
阅读全文 →
PubMedJournal of medicinal food2026-11-18

Picropodophyllotoxin Attenuates LPS-Induced Pulmonary Endothelial Inflammation and Lung Injury via the Nrf2/HO-1 Signaling Axis.

Cho Sanghee S, Kim Ga Eun GE, Han Gyuri G, Bae Jong-Sup JS

This investigation sought to determine whether picropodophyllotoxin (PPT)-a primary bioactive compound extracted from the roots of Podophyllum hexandrum-exerts protective effects against inflammation triggered by lipopolysaccharide (LPS). Using cultured human pulmonary artery endothelial cells (HPAECs) stimulated with LPS, we assessed the modulatory effects of PPT on heme oxygenase-1 (HO-1), cyclooxygenase (COX-2), and inducible nitric oxide synthase (iNOS). Furthermore, the impact of PPT on iNOS, tumor necrosis factor-alpha (TNF-α), and interleukin-1β (IL-1β) was evaluated in LPS-challenged mice. The experimental results demonstrated that PPT upregulated HO-1 expression, blocked NF-κB activation, reduced COX-2/prostaglandin E2 and iNOS/nitric oxide (NO) production, and attenuated STAT protein phosphorylation. Additionally, PPT facilitated the nuclear translocation of Nrf2, enabling its binding to antioxidant response elements, which subsequently led to decreased IL-1β levels in LPS-exposed HPAECs. Notably, the PPT-mediated suppression of iNOS/NO was abolished when HO-1 was silenced via RNA interference. In the in vivo model, PPT markedly inhibited iNOS expression in pulmonary tissues and lowered TNF-α concentrations in bronchoalveolar lavage fluid. Overall, these findings demonstrate that PPT exerts anti-inflammatory and endothelial-protective effects in the pulmonary context and highlight its potential as a therapeutic candidate for acute lung injury and other pulmonary inflammatory disorders associated with endothelial dysfunction.

PMID 43046273
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多alpha-1 antitrypsin